MHRA is examining whether those affected have a genetic trait that is leaving them at a greater risk of side effects from the ...

Police agencies worldwide seized $65 million (€57.2 million) worth of counterfeit or unapproved medicines in a major ...

Researchers suggest people taking Ozempic and similar drugs may face double the risk of developing wet age-related macular ...

At the diabetes conference, Eli Lilly presented results of a phase 1 trial of its experimental drug, eloralintide. Unlike GLP-1 drugs, it targets a hormone that slows stomach emptying. Over 12 weeks, ...

NICE says that in some exceptional circumstances the BMI requirements can drop down to 30, and people from some ethnic ...

Three months since Suzanne Harrington was prescribed the weight-loss jab Mounjaro, she opens up her diary and reveals all ...

Eli Lilly (NYSE: LLY) has been on fire over the past two years. The drugmaker has generated excellent financial results and ...

Novo Nordisk A/S (NYSE:NVO) stock dropped 2.1% premarket following news that Spain’s health ministry has requested clarification about the company’s obesity awareness campaign, which may have violated ...

Diabetes drug Ozempic and weight-loss jab Wegovy may also reduce the risk of dementia, according to a new study. American ...

If the drug is more broadly used in people with obesity and not just diabetes, those with higher body weights may see even ...

Berger Montague investigates Hims and Hers after stock drops 26% following Novo Nordisk's termination of GLP-1 drug partnership.

Supermarkets are selling fewer groceries thanks to an uptick in Brits taking weight-loss drugs including Wegovy and Mounjaro, ...